Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 December 2023 | Story Leonie Bolleurs | Photo Supplied
3D-Printed Sculptural Artefact
The 3D-printed sculptural artefact entered by a group of third-years from the UFS.

A group of third-year students from the UFS Department of Architecture exhibited their work at the 2023 Venice Biennale, an international architecture exhibition showcasing ground-breaking architectural work from various countries around the world.

The contributions of world-class architects, researchers, and institutions in architecture are exhibited at this exhibition. “To be featured in this exhibition means that we are recognised by the international community as one of the leading architectural learning sites in South Africa and the work being produced at the institution deserves international acclaim,” says Phadi Mabe, Lecturer in the department.

The students representing the university with Mabe and participating in this event are Anya Strydom, Yamkelwa Simelane, Jan Truter, and Khalipha Radebe.

Mabe says the artefact produced from this project is a 3D-printed sculptural device that shows the translation between sound and object and illustrates the sound data through 3D-printed forms. “The sound structures of South Africa’s languages are mapped three-dimensionally to create a visual and spatial record of language. This unique artefact demonstrates that there are uncharted terrains in architecture, suggesting alternative dimensions that can be extrapolated to show that architecture can represent the intangible” he explains.

The UFS artefact was one of six design artefacts selected for the 18th International Architecture Exhibition – La Biennale di Venezia, which opened to the public in May and closes on 26 November 2023.

Hosted by the Department of Sport, Arts and Culture, the competition involved an emphasis on students incorporating African traditional architecture into their design models.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept